Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury

Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI)...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2022-04, Vol.14 (4), p.e24221
Main Authors: Najar, Hatem, Tuider, Laurene, Kukkar, Vinita, Quasem, Mohammad
Format: Article
Language:English
Subjects:
Anemia
Apheresis
Blood
Blood platelets
Case reports
Creatinine
Dehydrogenases
Health services
Hematology
Hemodialysis
Hemoglobin
Hospitals
Immunotherapy
Internal Medicine
Kidneys
Monoclonal antibodies
Nephrology
Patients
Penis
Purpura
Thrombocytopenia
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c266t-cd2b1d074a166a928d76986e1eb12cf8e9d214e469aacfd53cd93f2926dbb8263
container_end_page
container_issue 4
container_start_page e24221
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Najar, Hatem
Tuider, Laurene
Kukkar, Vinita
Quasem, Mohammad
description Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.
doi_str_mv 10.7759/cureus.24221
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9113771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671872825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c266t-cd2b1d074a166a928d76986e1eb12cf8e9d214e469aacfd53cd93f2926dbb8263</originalsourceid><addsrcrecordid>eNpVUU1PAjEQbYxGCHLzbDbxKtjOLm3XgwkhfhBJMIrnptvOyhLYYndLwr93FSR4mjczL29e5hFyyWhfiEF6a4LHUPUhAWAnpA2My55kMjk9wi3SraoFpZRRAVTQc9KKB5yCTFibTGdz71aZqwsT7aHZ1m6NZTN4DX4dvL6LhtGb9hiNdKgwcnn0jhts-qEJNUYvhS1xG43LRfDbC3KW62WF3X3tkI_Hh9nouTeZPo1Hw0nPAOd1z1jImKUi0YxznYK0gqeSI8OMgcklphZYgglPtTa5HcTGpnEOKXCbZRJ43CH3O911yFZoDZa110u19sVK-61yulD_N2UxV59uo1LGYiFYI3C9F_DuK2BVq4ULvmw8K-CCSQESBg3rZscy3lWVx_xwgVH1k4DaJaB-E2joV8euDuS_f8ffOaiDjw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671872825</pqid></control><display><type>article</type><title>Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Najar, Hatem ; Tuider, Laurene ; Kukkar, Vinita ; Quasem, Mohammad</creator><creatorcontrib>Najar, Hatem ; Tuider, Laurene ; Kukkar, Vinita ; Quasem, Mohammad</creatorcontrib><description>Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.24221</identifier><identifier>PMID: 35602841</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Anemia ; Apheresis ; Blood ; Blood platelets ; Case reports ; Creatinine ; Dehydrogenases ; Health services ; Hematology ; Hemodialysis ; Hemoglobin ; Hospitals ; Immunotherapy ; Internal Medicine ; Kidneys ; Monoclonal antibodies ; Nephrology ; Patients ; Penis ; Purpura ; Thrombocytopenia</subject><ispartof>Curēus (Palo Alto, CA), 2022-04, Vol.14 (4), p.e24221</ispartof><rights>Copyright © 2022, Najar et al.</rights><rights>Copyright © 2022, Najar et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Najar et al. 2022 Najar et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c266t-cd2b1d074a166a928d76986e1eb12cf8e9d214e469aacfd53cd93f2926dbb8263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2671872825/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2671872825?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35602841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Najar, Hatem</creatorcontrib><creatorcontrib>Tuider, Laurene</creatorcontrib><creatorcontrib>Kukkar, Vinita</creatorcontrib><creatorcontrib>Quasem, Mohammad</creatorcontrib><title>Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.</description><subject>Anemia</subject><subject>Apheresis</subject><subject>Blood</subject><subject>Blood platelets</subject><subject>Case reports</subject><subject>Creatinine</subject><subject>Dehydrogenases</subject><subject>Health services</subject><subject>Hematology</subject><subject>Hemodialysis</subject><subject>Hemoglobin</subject><subject>Hospitals</subject><subject>Immunotherapy</subject><subject>Internal Medicine</subject><subject>Kidneys</subject><subject>Monoclonal antibodies</subject><subject>Nephrology</subject><subject>Patients</subject><subject>Penis</subject><subject>Purpura</subject><subject>Thrombocytopenia</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVUU1PAjEQbYxGCHLzbDbxKtjOLm3XgwkhfhBJMIrnptvOyhLYYndLwr93FSR4mjczL29e5hFyyWhfiEF6a4LHUPUhAWAnpA2My55kMjk9wi3SraoFpZRRAVTQc9KKB5yCTFibTGdz71aZqwsT7aHZ1m6NZTN4DX4dvL6LhtGb9hiNdKgwcnn0jhts-qEJNUYvhS1xG43LRfDbC3KW62WF3X3tkI_Hh9nouTeZPo1Hw0nPAOd1z1jImKUi0YxznYK0gqeSI8OMgcklphZYgglPtTa5HcTGpnEOKXCbZRJ43CH3O911yFZoDZa110u19sVK-61yulD_N2UxV59uo1LGYiFYI3C9F_DuK2BVq4ULvmw8K-CCSQESBg3rZscy3lWVx_xwgVH1k4DaJaB-E2joV8euDuS_f8ffOaiDjw</recordid><startdate>20220417</startdate><enddate>20220417</enddate><creator>Najar, Hatem</creator><creator>Tuider, Laurene</creator><creator>Kukkar, Vinita</creator><creator>Quasem, Mohammad</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220417</creationdate><title>Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury</title><author>Najar, Hatem ; Tuider, Laurene ; Kukkar, Vinita ; Quasem, Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c266t-cd2b1d074a166a928d76986e1eb12cf8e9d214e469aacfd53cd93f2926dbb8263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anemia</topic><topic>Apheresis</topic><topic>Blood</topic><topic>Blood platelets</topic><topic>Case reports</topic><topic>Creatinine</topic><topic>Dehydrogenases</topic><topic>Health services</topic><topic>Hematology</topic><topic>Hemodialysis</topic><topic>Hemoglobin</topic><topic>Hospitals</topic><topic>Immunotherapy</topic><topic>Internal Medicine</topic><topic>Kidneys</topic><topic>Monoclonal antibodies</topic><topic>Nephrology</topic><topic>Patients</topic><topic>Penis</topic><topic>Purpura</topic><topic>Thrombocytopenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Najar, Hatem</creatorcontrib><creatorcontrib>Tuider, Laurene</creatorcontrib><creatorcontrib>Kukkar, Vinita</creatorcontrib><creatorcontrib>Quasem, Mohammad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Najar, Hatem</au><au>Tuider, Laurene</au><au>Kukkar, Vinita</au><au>Quasem, Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2022-04-17</date><risdate>2022</risdate><volume>14</volume><issue>4</issue><spage>e24221</spage><pages>e24221-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Thrombotic microangiopathy (TMA) is a serious and potentially fatal disorder, especially if there is a delay in diagnosis and appropriate treatment. Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are the two main forms of TMA. Although severe acute kidney injury (AKI) is a common manifestation of TMA, it remains rarely described in reported TTP cases. We present a rare case of TTP in a 76-year-old African American male who presented with severe AKI (stage 3) and uremic symptoms. Early diagnosis and prompt treatment of TTP with plasmapheresis followed by rituximab and caplacizumab were associated with the resolution of the AKI and avoidance of hemodialysis. This case highlights the need to consider TTP as a possible diagnosis even in the setting of severe AKI.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>35602841</pmid><doi>10.7759/cureus.24221</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-04, Vol.14 (4), p.e24221
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9113771
source Publicly Available Content Database; PubMed Central
subjects Anemia
Apheresis
Blood
Blood platelets
Case reports
Creatinine
Dehydrogenases
Health services
Hematology
Hemodialysis
Hemoglobin
Hospitals
Immunotherapy
Internal Medicine
Kidneys
Monoclonal antibodies
Nephrology
Patients
Penis
Purpura
Thrombocytopenia
title Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A57%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombotic%20Thrombocytopenic%20Purpura:%20A%20Rare%20Cause%20of%20Severe%20Acute%20Kidney%20Injury&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Najar,%20Hatem&rft.date=2022-04-17&rft.volume=14&rft.issue=4&rft.spage=e24221&rft.pages=e24221-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.24221&rft_dat=%3Cproquest_pubme%3E2671872825%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c266t-cd2b1d074a166a928d76986e1eb12cf8e9d214e469aacfd53cd93f2926dbb8263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2671872825&rft_id=info:pmid/35602841&rfr_iscdi=true